CM
CLBT icon

Churchill Management’s Cellebrite CLBT Stock Holding History

Churchill Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,863
Closed -$1.05M – 151
2025
Q1 		$1.05M Sell
53,863
-5,869
-10% -$124K 0.01% 129
2024
Q4 		$1.32M Sell
59,732
-5,107
-8% -$98.3K 0.01% 134
2024
Q3 		$1.09M Buy
+64,839
New +$962K 0.01% 135

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Churchill Management's CLBT Position: Q2 2025 in Review

Churchill Management sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 53,863 shares — an estimated $1.05M sold.

Churchill Management first reported a position in CLBT in Q3 2024 and held it in 3 quarters. The position peaked at $1.32M in Q4 2024. 208 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Churchill Management reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Churchill Management sold 53,863 Cellebrite shares in Q2 2025, an estimated $1.05M.
  • Churchill Management first reported a position in Cellebrite in Q3 2024 and held it in 3 quarters.
  • Churchill Management's Cellebrite position peaked at $1.32M in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Churchill Management's 13F filing for Q2 2025, filed 18 Jul 2025.